Cancer Causes & Control

, Volume 24, Issue 2, pp 365–371

Use of antihypertensive medications and breast cancer risk

  • Babette S. Saltzman
  • Noel S. Weiss
  • Weiva Sieh
  • Annette L. Fitzpatrick
  • Anne McTiernan
  • Janet R. Daling
  • Christopher I. Li
Original paper

DOI: 10.1007/s10552-012-0122-8

Cite this article as:
Saltzman, B.S., Weiss, N.S., Sieh, W. et al. Cancer Causes Control (2013) 24: 365. doi:10.1007/s10552-012-0122-8

Abstract

Purpose

Use of specific antihypertensive medications (AHTs) has been hypothesized to increase breast cancer risk, but results across published studies are inconsistent.

Methods

We re-evaluated the relationship between AHT use and breast cancer risk in a prospective cohort of 3,201 women ≥65 years of age at recruitment now with more than double the length of follow-up (12 vs. 5 years) and substantially more breast cancer diagnoses (188 compared with 75 cases). We estimated the association between AHT use overall as well as use of specific formulations (based on data collected annually) and breast cancer risk using multivariate-adjusted Cox regression.

Results

Compared with women who reported no use of AHTs, women who had used calcium channel blockers (CCB) within the past two years had a 1.6-fold increased risk of breast cancer (95 % confidence interval (CI): 1.0–2.5), and in particular, recent users of immediate-release CCBs had a 2.4-fold increased risk (95 % CI: 1.3–4.5). Neither ever nor recent use of any other type of AHT was associated with breast cancer risk.

Conclusions

While the observed association between immediate-release CCBs and breast cancer risk is based on a small sample size and needs to be interpreted cautiously, this result is consistent with others in the literature. However, given declines in use of these preparations in favor of sustained-release CCBs, which was not related to risk, the potential clinical and public health impact of this association is limited. This study also adds to the evidence that other commonly used AHTs are not strongly related to breast cancer risk.

Keywords

Breast cancerEtiologyEpidemiologyRisk factorsAntihypertensive medications

Copyright information

© Springer Science+Business Media Dordrecht 2012

Authors and Affiliations

  • Babette S. Saltzman
    • 1
    • 2
    • 3
  • Noel S. Weiss
    • 1
    • 2
  • Weiva Sieh
    • 4
  • Annette L. Fitzpatrick
    • 2
  • Anne McTiernan
    • 1
    • 2
  • Janet R. Daling
    • 1
    • 2
  • Christopher I. Li
    • 1
    • 2
  1. 1.Division of Public Health SciencesFred Hutchinson Cancer Research CenterSeattleUSA
  2. 2.Department of EpidemiologyUniversity of WashingtonSeattleUSA
  3. 3.Seattle Children’s HospitalSeattleUSA
  4. 4.Department of Health Research and PolicyStanford University School of MedicineStanfordUSA